FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4310112920> ?p ?o ?g. }

• W4310112920 endingPage "12841" @default.
• W4310112920 startingPage "12840" @default.
• W4310112920 abstract "Introduction: Acute myelogenous leukemia (AML) is a major indication for allogeneic hematopoietic cell transplantation (alloHCT). Myeloablative (MAC) regimens are preferred for their intensity, however, reduced intensity conditioning regimens (RIC) have been increasingly used to permit older patients and patients with comorbidities to undergo transplant. The literature is conflicting regarding the comparison of outcomes between RIC and MAC patients. While MAC regimens are associated with less relapse, non-relapse mortality (NRM) is higher. RIC regimens on the other hand, demonstrate less NRM but higher relapse rates. We sought to compare RIC vs MAC regimens at our centre for alloHCT of AML in complete remission (CR). Methods: We retrospectively analyzed the outcomes of 451 patients that underwent alloHCT for AML at the Princess Margaret Cancer Centre (PMCC) with either RIC or MAC using various donors between the years 2015-2020. Primary endpoint was 2-year overall survival (OS), secondary endpoints included cumulative incidence of relapse (CIR), cumulative NRM, and GVHD free/relapse free survival (GRFS). Conditioning regimen intensity was determined as defined by Bacigalupo et al (BBMT 2009). Of the total cohort 331 patients received RIC and 121 MAC. Among MAC regimens, 59% received FLU(4)Bu(4) (Fludarabine 140mg/m2 + Busulfan 12.8mg/m2). Among RIC patients 71% received Flu(4)Bu(2)TBI(200) (Fludarabine 140mg/m2+ Busulfan 6.4 mg/m2 + TBI 200cGy). Results: Median age at transplant was 48 years (range: 19-67) for MAC recipients and 61 (range: 18-75) for RIC recipients (p<0.001). Other patient characteristics are described in Table 1. For the entire cohort at 2 years, the incidence of NRM was 19.1% for MAC (95% CI: 12.4-26.8) and 22.5% for RIC (95% CI: 18.1-27.1) (p=0.44). Two-year CIR was 19.8% (95% CI: 12.9-27.8) for MAC recipients and 24.5% (95% CI: 20.0-29.4) for RIC recipients (p=0.15). Two-year OS was 61% and 53% for MAC and RIC, respectively (p=0.02). Acute GVHD occurred in 58.3% of MAC recipients versus 46.8% of RIC recipients. Chronic GVHD occurred in 43.3% of the MAC recipients versus 38% of the RIC recipients. At two years GRFS was 40.8% (95% CI: 35.4-46.1) for MAC and 33.7% (95% CI: 25.0-42.6) for RIC, p=0.30. When examining the Disease Risk Index (DRI) for the entire cohort, OS for high risk was 43.3% (95% CI: 32.5-53.5) vs 66.6% (95% CI: 61-71) and 64% (95% CI: 38-80) for intermediate risk and low risk respectively, p<0.001. A propensity score (PS) matched analysis was done matching patients for age, HLA matching (mismatched vs full match), DRI (low, intermediate, high risk) and in vivo T cell depletion (yes vs no). Two-year OS was 67% for the MAC recipients (95% CI: 57-76) and 66% for the RIC recipients (95% CI: 56-75), p=0.95 (Figure 1a). NRM for MAC was 22% (95% CI: 14-30) versus 14% (95% CI: 8-22) for RIC, p=0.19. CIR at 2 years was 18.5% for MAC (95% CI 11-27) and 24.3% for RIC (95% CI: 16-33), p=0.22. GRFS at 2 years was 36% (95% CI: 26.4-45.7) for MAC and 48.3% (95% CI: 38-58) for RIC recipients, p=0.17. In the subgroup analysis examining matched related donor (MRD) recipients in particular, the OS at 2 years was for MAC 83.6% (95% CI: 66.8-91.3) vs 57.3% (95% CI: 45.1-67.7) for RIC, p=0.006 (Figure 1b) Two-year NRM was 10.3% for MAC vs 23.4% for the RIC group, p=0.14. CIR at 2 years was 12.2% for MAC vs 23.4% for RIC in the MRD setting, p=0.11. Conclusions: Our study shows that in the MRD setting there is a statistically significant improved survival, especially in patients with low and intermediate DRI scores. In other donor settings, there is no significant difference in outcomes between patients that undergo alloHCT with MAC vs RIC regimens. MAC conditioning regimens should continue to be the preferred choice of intensity for patients that may tolerate it. Figure 1View largeDownload PPTFigure 1View largeDownload PPT Close modal" @default.
• W4310112920 created "2022-11-30" @default.
• W4310112920 creator A5010175168 @default.
• W4310112920 creator A5014346242 @default.
• W4310112920 creator A5017586094 @default.
• W4310112920 creator A5038048073 @default.
• W4310112920 creator A5040159118 @default.
• W4310112920 creator A5045765371 @default.
• W4310112920 creator A5051261755 @default.
• W4310112920 creator A5071646305 @default.
• W4310112920 creator A5072952978 @default.
• W4310112920 creator A5073179735 @default.
• W4310112920 creator A5080055664 @default.
• W4310112920 creator A5082983425 @default.
• W4310112920 creator A5090941351 @default.
• W4310112920 date "2022-11-15" @default.
• W4310112920 modified "2023-10-01" @default.
• W4310112920 title "Influence of Conditioning Regimen Intensity on Outcomes Post-Allogeneic Transplantation for AML in Complete Morphological Remission" @default.
• W4310112920 doi "https://doi.org/10.1182/blood-2022-162279" @default.
• W4310112920 hasPublicationYear "2022" @default.
• W4310112920 type Work @default.
• W4310112920 citedByCount "0" @default.
• W4310112920 crossrefType "journal-article" @default.
• W4310112920 hasAuthorship W4310112920A5010175168 @default.
• W4310112920 hasAuthorship W4310112920A5014346242 @default.
• W4310112920 hasAuthorship W4310112920A5017586094 @default.
• W4310112920 hasAuthorship W4310112920A5038048073 @default.
• W4310112920 hasAuthorship W4310112920A5040159118 @default.
• W4310112920 hasAuthorship W4310112920A5045765371 @default.
• W4310112920 hasAuthorship W4310112920A5051261755 @default.
• W4310112920 hasAuthorship W4310112920A5071646305 @default.
• W4310112920 hasAuthorship W4310112920A5072952978 @default.
• W4310112920 hasAuthorship W4310112920A5073179735 @default.
• W4310112920 hasAuthorship W4310112920A5080055664 @default.
• W4310112920 hasAuthorship W4310112920A5082983425 @default.
• W4310112920 hasAuthorship W4310112920A5090941351 @default.
• W4310112920 hasBestOaLocation W43101129201 @default.
• W4310112920 hasConcept C105795698 @default.
• W4310112920 hasConcept C126322002 @default.
• W4310112920 hasConcept C141071460 @default.
• W4310112920 hasConcept C143998085 @default.
• W4310112920 hasConcept C2776694085 @default.
• W4310112920 hasConcept C2777408962 @default.
• W4310112920 hasConcept C2781413609 @default.
• W4310112920 hasConcept C2911091166 @default.
• W4310112920 hasConcept C2993801483 @default.
• W4310112920 hasConcept C3018657049 @default.
• W4310112920 hasConcept C33923547 @default.
• W4310112920 hasConcept C45262634 @default.
• W4310112920 hasConcept C71924100 @default.
• W4310112920 hasConceptScore W4310112920C105795698 @default.
• W4310112920 hasConceptScore W4310112920C126322002 @default.
• W4310112920 hasConceptScore W4310112920C141071460 @default.
• W4310112920 hasConceptScore W4310112920C143998085 @default.
• W4310112920 hasConceptScore W4310112920C2776694085 @default.
• W4310112920 hasConceptScore W4310112920C2777408962 @default.
• W4310112920 hasConceptScore W4310112920C2781413609 @default.
• W4310112920 hasConceptScore W4310112920C2911091166 @default.
• W4310112920 hasConceptScore W4310112920C2993801483 @default.
• W4310112920 hasConceptScore W4310112920C3018657049 @default.
• W4310112920 hasConceptScore W4310112920C33923547 @default.
• W4310112920 hasConceptScore W4310112920C45262634 @default.
• W4310112920 hasConceptScore W4310112920C71924100 @default.
• W4310112920 hasIssue "Supplement 1" @default.
• W4310112920 hasLocation W43101129201 @default.
• W4310112920 hasOpenAccess W4310112920 @default.
• W4310112920 hasPrimaryLocation W43101129201 @default.
• W4310112920 hasRelatedWork W1851748442 @default.
• W4310112920 hasRelatedWork W1996758827 @default.
• W4310112920 hasRelatedWork W2035143696 @default.
• W4310112920 hasRelatedWork W2083922301 @default.
• W4310112920 hasRelatedWork W2316269512 @default.
• W4310112920 hasRelatedWork W2377321712 @default.
• W4310112920 hasRelatedWork W4205111714 @default.
• W4310112920 hasRelatedWork W4297614821 @default.
• W4310112920 hasRelatedWork W4297614822 @default.
• W4310112920 hasRelatedWork W4297615103 @default.
• W4310112920 hasVolume "140" @default.
• W4310112920 isParatext "false" @default.
• W4310112920 isRetracted "false" @default.
• W4310112920 workType "article" @default.